Cargando…

Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin

Citrus × aurantium L., Chinese name: Fructus Aurantii (FA) has been largely used as Qi-invigorating herb in China for centuries. The main components (meranzin hydrate, naringin, neohesperidin, meranzin, nobiletin) have good physiological activity with relatively high abundance in FA. Few multi-compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jinbin, Wei, Feiting, Luo, Xizhen, Zhang, Min, Qiao, Rifa, Zhong, Minyong, Chen, Haifang, Yang, Wuliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319089/
https://www.ncbi.nlm.nih.gov/pubmed/32636752
http://dx.doi.org/10.3389/fphar.2020.00933
_version_ 1783550985207021568
author Yuan, Jinbin
Wei, Feiting
Luo, Xizhen
Zhang, Min
Qiao, Rifa
Zhong, Minyong
Chen, Haifang
Yang, Wuliang
author_facet Yuan, Jinbin
Wei, Feiting
Luo, Xizhen
Zhang, Min
Qiao, Rifa
Zhong, Minyong
Chen, Haifang
Yang, Wuliang
author_sort Yuan, Jinbin
collection PubMed
description Citrus × aurantium L., Chinese name: Fructus Aurantii (FA) has been largely used as Qi-invigorating herb in China for centuries. The main components (meranzin hydrate, naringin, neohesperidin, meranzin, nobiletin) have good physiological activity with relatively high abundance in FA. Few multi-component comparative pharmacokinetics are simultaneously accessible for the flavone glycosides, polymethoxy flavones, and coumarins in FA. In this work, a reliable and rapid ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was established and validated to determine the five ingredients in the SD rat plasma, and further applied to the pharmacokinetic studies after oral administration of monomer, drugs in compatibility, and FA extract. After hydrolysis with β-glucuronidase and sulfatase, the concentration of naringin and neohesperidin in rat plasma were expressed respectively by the total concentration of naringenin and hesperitin which was determined by UPLC-MS/MS. Double-peak phenomenon was observed for naringin and neohesperidin, which may be due to the enterohepatic circulation or multiple site absorption of the two flavone glycosides. Meranzin hydrate and meranzin (coumarins) were absorbed rapidly (T(max,) about 1.0 h) but eliminated slowly (t(1/2z) exceeds 6.5 h). Nobiletin, a typical polymethoxy flavone, was also rapidly absorbed according to T(max) and AUC((0-t)). DAS 3.1 software suggests the pharmacokinetic profiles of the five components in rats be depicted as a two-compartment pharmacokinetic model. There were significant differences in pharmacokinetic parameters for naringenin and hesperetin between the compatibility, FA extract group vs monomer group: ① remarkable increases in the values of AUC((0–∞)), AUC((0–t)) and C(max); ② obvious decrease of CL(Z/F); and ③ longer t(max) and t(1/2z). The results suggest that compatibility can promote mutual absorption and affect the elimination behaviors.
format Online
Article
Text
id pubmed-7319089
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73190892020-07-06 Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin Yuan, Jinbin Wei, Feiting Luo, Xizhen Zhang, Min Qiao, Rifa Zhong, Minyong Chen, Haifang Yang, Wuliang Front Pharmacol Pharmacology Citrus × aurantium L., Chinese name: Fructus Aurantii (FA) has been largely used as Qi-invigorating herb in China for centuries. The main components (meranzin hydrate, naringin, neohesperidin, meranzin, nobiletin) have good physiological activity with relatively high abundance in FA. Few multi-component comparative pharmacokinetics are simultaneously accessible for the flavone glycosides, polymethoxy flavones, and coumarins in FA. In this work, a reliable and rapid ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was established and validated to determine the five ingredients in the SD rat plasma, and further applied to the pharmacokinetic studies after oral administration of monomer, drugs in compatibility, and FA extract. After hydrolysis with β-glucuronidase and sulfatase, the concentration of naringin and neohesperidin in rat plasma were expressed respectively by the total concentration of naringenin and hesperitin which was determined by UPLC-MS/MS. Double-peak phenomenon was observed for naringin and neohesperidin, which may be due to the enterohepatic circulation or multiple site absorption of the two flavone glycosides. Meranzin hydrate and meranzin (coumarins) were absorbed rapidly (T(max,) about 1.0 h) but eliminated slowly (t(1/2z) exceeds 6.5 h). Nobiletin, a typical polymethoxy flavone, was also rapidly absorbed according to T(max) and AUC((0-t)). DAS 3.1 software suggests the pharmacokinetic profiles of the five components in rats be depicted as a two-compartment pharmacokinetic model. There were significant differences in pharmacokinetic parameters for naringenin and hesperetin between the compatibility, FA extract group vs monomer group: ① remarkable increases in the values of AUC((0–∞)), AUC((0–t)) and C(max); ② obvious decrease of CL(Z/F); and ③ longer t(max) and t(1/2z). The results suggest that compatibility can promote mutual absorption and affect the elimination behaviors. Frontiers Media S.A. 2020-06-19 /pmc/articles/PMC7319089/ /pubmed/32636752 http://dx.doi.org/10.3389/fphar.2020.00933 Text en Copyright © 2020 Yuan, Wei, Luo, Zhang, Qiao, Zhong, Chen and Yang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yuan, Jinbin
Wei, Feiting
Luo, Xizhen
Zhang, Min
Qiao, Rifa
Zhong, Minyong
Chen, Haifang
Yang, Wuliang
Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
title Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
title_full Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
title_fullStr Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
title_full_unstemmed Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
title_short Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
title_sort multi-component comparative pharmacokinetics in rats after oral administration of fructus aurantii extract, naringin, neohesperidin, and naringin-neohesperidin
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319089/
https://www.ncbi.nlm.nih.gov/pubmed/32636752
http://dx.doi.org/10.3389/fphar.2020.00933
work_keys_str_mv AT yuanjinbin multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT weifeiting multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT luoxizhen multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT zhangmin multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT qiaorifa multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT zhongminyong multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT chenhaifang multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin
AT yangwuliang multicomponentcomparativepharmacokineticsinratsafteroraladministrationoffructusaurantiiextractnaringinneohesperidinandnaringinneohesperidin